Legal & General Group PLC Kaleido Biosciences, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.05 - $1.7 $94 - $3,204	-1,885 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.82 - $8.72 $2,793 - $4,185	480 Added 34.16%	1,885 $14,000
Q3 2020 Nov 13, 2020	SELL	$5.09 - $11.07 $519 - $1,129	-102 Reduced 6.77%	1,405 $16,000
Q2 2020 Aug 14, 2020	SELL	$4.62 - $8.01 $609 - $1,057	-132 Reduced 8.05%	1,507 $11,000
Q1 2020 May 14, 2020	SELL	$3.62 - $9.49 $1,723 - $4,517	-476 Reduced 22.51%	1,639 $10,000
Q4 2019 Feb 13, 2020	BUY	$5.02 - $8.87 $6,259 - $11,060	1,247 Added 143.66%	2,115 $11,000
Q2 2019 Aug 14, 2019	BUY	$11.25 - $18.1 $9,765 - $15,710	868 New	868 $10,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.